Analysis of association between histamine receptor gene HRH1, HRH2, HRH3, HRH4 polymorphisms and asthma in children

Asthma is a common multifactorial disease characterized by chronic inflammation of the respiratory tract. Insufficient control of asthma symptoms significantly reduces the patient’s quality of life, leads to the risk for more severe disease and disability. It is important to research the role of gene polymorphisms encoding proteins involved in various stages of histamine metabolism, which is one of the known mediators of allergic reactions.

The aim of the study was to investigate histamine receptor gene polymorphisms (HRH1, HRH2, HRH3, HRH4) in children with asthma and the control group.

Methods. The study of HRH1 (rs901865), HRH2 (rs2067474), HRH3 (rs3787429), HRH4 (rs11665084) gene polymorphisms in asthma patients and healthy individuals aged 2 - 17 years of different ethnicities living in the Republic of Bashkortostan was carried out. Genotyping of polymorphisms was performed by polymerase chain reaction with fluorescence detection.

Results. In Tatars, rs901865*CT genotype and rs901865*T allele of HRH1 gene were associated with asthma development and decrease in spirometry measures (MEF25). In Tatars, a statistically significant model of the interaction between HRH1 (rs901865), HRH3 (rs3787429), and HRH4 (rs11665084) gene polymorphisms that leads to the risk of asthma was established.

Conclusion. The results of this study reveal certain aspects of asthma pathogenesis and suggest the possible involvement of polymorphic variants of histamine receptors genes HRH1, HRH3, HRH4 in the development of asthma.

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2020. Available at: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf

2. Chuchalin A.G., Khaltaev N., Antonov N. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 963-974. DOI: 10.2147/COPD.S67283.

3. Batozhargalova B.Ts., Mizernitskiy Yu.L., Podol’naya M.A. [Meta-analysis of the prevalence of asthma-like symptoms and asthma in Russia (according to the results of ISAAC)]. Rossiyskiy vestnik perinatologii ipediatrii. 2016; 61 (4): 59-69. DOI: 10.21508/1027-4065-2016-61-4-59-69 (in Russian).

4. Chuchalin A.G., ed. [National program “Bronchial asthma in children. Treatment strategy and prevention”]. 5rd ed. Moscow: Origi-nal-maket; 2017 (in Russian).

5. Anvari S., Vyhlidal C.A., Dai H., Jones B.L. Genetic variation along the histamine pathway in children with allergic versus nonallergic asthma. Am. J. Respir. Cell. Mol. Biol. 2015; 53 (6): 802-809. DOI: 10.1165/rcmb.2014-0493OC.

6. Jones B.L., Kearns G.L. Histamine: new thoughts about a familiar mediator. Clin. Pharmacol. Ther. 2011; 89 (2): 189-197. DOI: 10.1038/clpt.2010.256.

7. Lutsenko M.T. [Morphofunctional characteristic of histamine effect on bronchial mucosa in asthma]. Byulleten’fiziologii ipatologii dykhaniya. 2016; (59): 36-40. Available at: https://cfpd.elpub.ru/jour/article/view/898 (in Russian).

8. Kucher A.N. Association of polymorphic variants of key histamine metabolism genes and histamine receptor genes with multifactorial diseases. Russ. J. Genet. 2019; 55 (7): 794-814. DOI: 10.1134/S102279541907010X.

9. Jones B.L., Sherwin C.M., Liu X. et al. Genetic variation in the histamine production, response, and degradation pathway is associated with histamine pharmacodynamic response in children with asthma. Front. Pharmacol. 2017; 7: 524. DOI: 10.3389/fphar.2016.00524.

10. Gu J., Mao X.H., Yang X.Z. et al. Histamine H4 receptor gene polymorphisms: a potential predictor of oral H1 antihistamine efficacy for allergic rhinitis. Int. Forum Allergy Rhinol. 2017; 7 (3): 268-275. DOI: 10.1002/alr.21870.

11. Chu J.T. Histamine H1 receptor gene polymorphism acts as a biological indicator of the prediction of the rapeutic efficacy in patients with allergic rhinitis in the Chinese Han population. J. Cell Biochem. 2019; 120 (1): 164-170. DOI: 10.1002/jcb.27278.

12. Chuchalin A.G., ed. [National program “Bronchial asthma in children. Treatment strategy and prevention”]. 4rd ed. Moscow: Origi-nal-maket; 2017 (in Russian).

13. Element R.F., Zil’ber N.A. [Functional diagnostic studies in pulmonology: guidelines]. Saint-Petersburg; 1993 (in Russian).

14. Mathew C.C. The isolation ofhigh molecular weight eucariotic DNA. In: Walker J.M., ed. Nucleic Acids. Methods Molecular Biology. New Jork, London: Human Press Inc.; 1984. Vol. 2: 31-34. DOI: 10.1385/0-89603-064-4:31.

15. Ritchie M.D., Hahn L.W., Roodi N. et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 2001; 69 (1): 138-147. DOI: 10.1086/321276.

16. Isidoro-Garcia M., Sdnchez-Martin A., Garcia-Sdnchez A. et al. Pharmacogenetics and the treatment of asthma. Pharmacogenomics. 2017; 18 (13): 1271-1280. DOI: 10.2217/pgs-2017-0024.

17. Micallef S., Sasse A. Genetic polymorphisms in the histamine receptor family. In: Blandina P., Passani M.B., eds. Histamine Receptors: Preclinical and clinical aspects. Switzerland: Humana Press; 2016. Vol. 28: 51-74. DOI: 10.1007/978-3-319-40308-3_2.

18. Thangam E.B., Jemima E.A., Singh H. et al. The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. Front. Immunol. 2018; 9: 1873. DOI: 10.3389/fimmu.2018.01873.

19. Kordulewska N., Cieslinska A., Fiedorowicz E. et al. Effect of the fexofenadine on the expression of HRH-1 and HRH-4 receptor in peripheral blood mononuclear cell isolated from children with diagnosed allergy - in vitro study short communication. J. Pharm. Pham. Sci. 2019; 22 (1): 93-97. DOI: 10.18433/jpps29971.

20. Leary P.J., Kronmal RA., Bluemke DA. et al. Histamine H2 receptor polymorphisms, myocardial transcripts, and heart failure (from the multi-ethnic study of atherosclerosis and beta-blocker effect on remodeling and gene expression trial). Am. J. Cardiol. 2018; 121 (2): 256-261. DOI: 10.1016/j.amjcard.2017.10.016.

21. Alonso N., Zappia C.D., Cabrera M. et al. Physiological implications of biased signaling at histamine H2 receptors. Front. Pharmacol. 2015; 6: 45. DOI: 10.3389/fphar.2015.00045.

22. Arisawa T., Tahara T., Ozaki K. et al. Association between common genetic variant of HRH2 and gastric cancer risk. Int. J. Oncol. 2012; 41 (2): 497-503. DOI: 10.3892/ijo.2012.1482.

23. Ferreira M.A.R., Zhao Z.Z., Thomsen S.F. et al. Association and interaction analyses of eight genes under asthma linkage peaks. Allergy. 2009; 64 (11): 1623-1628. DOI: 10.1111/j.1398-9995.2009.02091.x.

24. He G.H., Cai W.K., Zhang J.B. Associations of polymorphisms in HRH2, HRH3, DAO, and HNMT genes with risk of chronic heart failure. Biomed. Res. Int. 2016; 2016: 1208476. DOI: 10.1155/2016/1208476.

25. Milldn-Guerrero R.O., Baltazar-Rodriguez L.M., Cdrdenas-Ro-jas M.I. et al. A280V polymorphism in the histamine H3 receptor as a risk factor for migraine. Arch. Med. Res. 2011; 42 (1): 44-47. DOI: 10.1016/j.arcmed.2011.01.009.

26. Jemima E.A., Prema A., Thangam E.B. Functional characterization of histamine H4 receptor on human mast cells. Mol. Immunol. 2014; 62 (1): 19-28. DOI: 10.1016/j.molimm.2014.05.007.

27. Simon T., Semsei A.F., Ungvari I. et. al. Asthma endophenotypes and polymorphisms in the histamine receptor HRH4gene. Int. Arch. Allergy Immunol. 2012; 159 (2): 109-120. DOI: 10.1159/000335919.

28. Ohsawa Y., Hirasawa N. The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study. Allergol. Int. 2014; 63 (4): 533-542. DOI: 10.2332/allergolint.13-RA-0675.